GRDN — GUARDIAN PHARMACY SVCS INC
As of Q2 2026, 33 SEC-registered investment managers reported holding GRDN (GUARDIAN PHARMACY SVCS INC) in their latest 13F filings, with a combined reported value of $428.26M across 10.24M shares. That is +1.5% by share count (+150.11K shares) versus the previous quarter, while reported value moved +12.8%. Ownership is concentrated: the five largest holders account for 79.8% of reported value and the top ten for 89.8%.
Compared with the prior quarter, 2 opened new positions, 17 added to existing stakes, 13 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
GRDN is classified in the Consumer Staples sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 3.24M | $135.73M | 0.01% | Add |
| Wellington Management Group history | Q2 2026 | 1.73M | $72.39M | 0.01% | Reduce |
| BlackRock Inc history | Q2 2026 | 1.58M | $65.99M | 0.00% | Reduce |
| Vanguard Group history | Q4 2025 | 1.35M | $40.73M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 966.21K | $40.46M | 0.01% | Add |
| Geode Capital Management history | Q2 2026 | 646.70K | $27.08M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 312.00K | $13.06M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 211.38K | $8.85M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 171.69K | $7.19M | 0.00% | Add |
| Lazard Asset Management history | Q2 2026 | 169.53K | $7.10M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 163.17K | $6.83M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 120.61K | $5.05M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 98.21K | $4.11M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 97.97K | $4.10M | 0.00% | Reduce |
| Royce & Associates history | Q2 2026 | 87.10K | $3.65M | 0.03% | Hold |
| Invesco Ltd history | Q2 2026 | 73.87K | $3.09M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 73.84K | $3.09M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 72.52K | $3.04M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 71.62K | $3.00M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 60.12K | $2.52M | 0.00% | Reduce |
New Positions (Q2 2026)
- JPMorgan Chase & Co 42.98K sh · $1.74M
- PNC Financial Services 89 sh · $3.73K
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 13.00K sh · $490.04K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | — | 1 | 145 | 117 | 250 | 1.82K | 2.36M | 3.24M |
| Wellington Management Group | 500.00K | 407.00K | 464.92K | 1.11M | 1.14M | 1.12M | 1.77M | 1.73M |
| BlackRock Inc | — | 488.32K | 534.02K | 912.27K | 1.55M | 1.74M | 1.76M | 1.58M |
| Franklin Resources | 500.00K | 513.03K | 738.58K | 976.21K | 1.06M | 991.38K | 952.95K | 966.21K |
| Geode Capital Management | — | 200.96K | 202.99K | 336.70K | 444.11K | 490.83K | 559.03K | 646.70K |
| Morgan Stanley | 376 | 22.43K | 16.02K | 32.97K | 158.88K | 146.25K | 116.97K | 312.00K |
| Northern Trust Corp | — | 72.99K | 76.94K | 108.87K | 166.99K | 238.06K | 189.25K | 211.38K |
| Goldman Sachs Group | 40.00K | 170.87K | 15.52K | 17.59K | 134.07K | 140.18K | 98.17K | 171.69K |
| Lazard Asset Management | 189.94K | 190.80K | 193.51K | 296.66K | 250.84K | 167.73K | 147.50K | 169.53K |
| Bank of America Corp | 51.44K | 49.17K | 52.44K | 48.70K | 206.14K | 68.80K | 128.05K | 163.17K |
| Millennium Management | 176.12K | — | 60.94K | 41.45K | 342.04K | 167.55K | 27.19K | 120.61K |
| Two Sigma Investments | 16.00K | — | — | 78.72K | 176.74K | 149.53K | 312.68K | 98.21K |
| Citadel Advisors | 401.13K | — | — | 319.25K | 77.66K | — | 579.12K | 97.97K |
| Royce & Associates | 75.00K | 214.00K | 273.07K | 255.65K | 268.14K | 186.12K | 87.10K | 87.10K |
| Invesco Ltd | — | — | — | — | 10.46K | 14.18K | 13.52K | 73.87K |
| D. E. Shaw & Co | — | — | — | — | 46.55K | 86.53K | 75.68K | 73.84K |
| UBS Group AG | — | 5.62K | 5.33K | 50.17K | 36.76K | 18.09K | 30.73K | 72.52K |
| BNY Mellon | — | 13.60K | 21.20K | 29.02K | 43.72K | 67.25K | 69.43K | 71.62K |
| Charles Schwab Investment Management | — | 26.85K | 26.91K | 38.59K | 60.49K | 101.30K | 114.73K | 60.12K |
| Renaissance Technologies | — | 141.10K | 104.06K | 36.70K | 146.60K | 121.60K | 99.99K | 44.80K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details